IBM extends financing arm to life sciences

IBM is expanding its IT financing business into healthcare, life sciences and pharmaceuticals.

IBM is expanding its IT financing business into healthcare, life sciences and pharmaceuticals.

Such financing is available now in the US to both new and existing customers, and will be expanded to Canada in the next few weeks, followed by other countries over time.

At first, global financing will focus on hospitals as a customer base and then will expand to life sciences, pharmaceutical and biotechnology customers, including those involved in research and development and academia," said global financing business development executive Terry Trierweiler.

"One thing we looked at very closely was the convergence of IT technology with medical technology and we noticed that the boundaries are getting blurred," she said. "It's really like a continuum of technology because in medical technology these days it's so computerised and digitised."

The IBM Global Financing sales force will not make specific recommendations about which manufacturers of medical equipment customers should choose. However, financing is available to cover medical technology equipment such as computerised tomography scanners, X-ray machines, ultrasound devices and the like.

IBM's hardware, software and services also can be financed. Financing is available for used equipment and lease options are also available.

IBM Global Financing representatives can help customers dispose of equipment they no longer want or track down used equipment.

Nancy Weil writes for IDG News Service

Read more on IT supplier relationship management

Start the conversation

Send me notifications when other members comment.

Please create a username to comment.